Rumors are going around that $HIMS (-2,98 %) not only a cooperation with $NOVO B (-1,83 %) with GLP1 but also with $LLY (+1,75 %) for diabetes and GLP, this would be very important for the business and would stand for security and diversification... what do you think?
